Chemicals in spinal fluid and blood during spinal cord stimulation for nerve pain
Part of Brain & nervous system, Pain clinical trials.
This study is testing a spinal cord stimulation treatment for long-term nerve pain. It will look at certain chemicals in your spinal fluid and blood to understand how the treatment works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have persistent spinal pain syndrome or complex regional pain syndrome.
- You have had neuropathic (nerve-related) pain for at least 6 months.
- You do not have a current drug or alcohol addiction.
- You do not have a malignant (cancerous) tumor, serious psychiatric disorder, active infection, or are not pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how spinal cord stimulation (a device that sends mild signals to the spinal cord) affects nerve pain after lumbar surgery. It also aims to help predict who is most likely to improve and why, comparing patients with and without certain sensory symptoms.
This study uses non-invasive brain monitoring to see how spinal cord stimulation may change brain activity in people with chronic nerve pain. It aims to better understand how treatment affects the brain and pain over time.
This trial studies whether changing the “stimulation pattern” of spinal cord stimulation can reduce long-lasting pain and improve daily function. You might be a good candidate if you have chronic trunk or leg pain and have already tried multiple pain treatments without enough relief.
This trial studies how psychological assessment can help people with long-term pain who are getting Spinal Cord Stimulation (SCS)—a treatment that uses mild electrical pulses to block pain signals. You may join if you've had chronic pain for at least 6 months, are eligible for SCS, and speak Italian.
This study tracks patients receiving spinal cord stimulation to understand long-term outcomes. It may help improve future treatment.
This trial tests whether stem cells injected near your spinal cord can improve pain relief from your existing spinal cord stimulator (BurstDR device). You're only eligible if your current stimulator is already helping with at least 50% pain reduction.
Hear when a new Neuropathic Pain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.